Galena Biopharma To Present At The 2013 BIO International Convention

LAKE OSWEGO, Ore., April 16, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Operating Officer, will present a corporate update at the 2013 BIO International Convention. The presentation will take place on Tuesday, April 23, 2013 at 8:45 a.m. CT at the McCormick Place convention center in Chicago, IL.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
CONTACT: Madeline Hatton         Toll free: +1 (855) 855-GALE (4253), ext. 109         info@galenabiopharma.com                  or                  Remy Bernarda         IR Sense, LLC         +1 (503) 400-6995         remy@irsense.com

Galena Biopharma, Inc.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More